Skip to main content
. 2022 Aug 3;79(9):920–931. doi: 10.1001/jamapsychiatry.2022.2066

Table. Multilevel Meta-analysis of Peripheral Markers of Nucleic Acid Damage From Oxidative Stress in Psychiatric Disorders, Including Subgroup Analyses and Sensitivity Analyses Excluding Low-Quality Studiesa.

Characteristic All studies Medium- and high-quality studies
Hedges g (95% CI) I2, % Hedges g (95% CI) I2, %
Blood cell DNA markers
No. of patient vs control group comparisons 30b NA 14 NA
Diagnostic group
DEM 1.32 (0.57 to 2.07)c NA NA NA
SUB 0.52 (−1.64 to 2.68) NA NA NA
PSY 0.70 (−0.10 to 1.50) NA 0.72 (−0.99 to 2.43) NA
BIP 1.54 (0.29 to 2.80)c NA 1.61 (−0.38 to 3.61) NA
MDD 1.37 (0.13 to 2.61)c NA 1.34 (−1.10 to 3.78) NA
ANX NA NA NA NA
Total 1.12 (0.69 to 1.55)c 92 1.14 (0.14 to 2.15)c 96
Plasma or serum DNA markers
No. of patient vs control group comparisons 33b NA 27b NA
Diagnostic group
DEM 0.07 (−1.77 to 1.91) NA 0.07 (−0.74 to 0.89) NA
SUB 0.70 (−0.38 to 1.78) NA 0.65 (0.16 to 1.15)c NA
PSY 1.08 (0.35 to 1.81)c NA 0.42 (−0.04 to 0.90) NA
BIP 0.81 (−0.28 to 1.91) NA 1.15 (0.51 to 1.79)c NA
MDD 0.61 (−0.01 to 1.24) NA 0.55 (0.26 to 0.83)c NA
ANX 0.53 (1.35 to 2.40) NA 0.53 (−0.36 to 1.41) NA
Total 0.75 (0.39 to 1.11)c 96 0.57 (0.37 to 0.77)c 84
Urine DNA markers
No. of patient vs control group comparisons 24b NA 22b NA
Diagnostic group
DEM 0.69 (0.29 to 1.10)c NA 0.70 (0.13 to 1.27)c NA
SUB NA NA NA NA
PSY 0.31 (0.09 to 0.70) NA 0.30 (−0.13 to 0.74) NA
BIP 0.66 (0.31 to 1.01)c NA 0.66 (0.27 to 1.05)c NA
MDD 0.02 (−0.33 to 0.38) NA 0.04 (−0.36 to 0.44) NA
ANX 0.20 (−0.66 to 1.07) NA 0.20 (−0.74 to 1.16) NA
Total 0.44 (0.20 to 0.68)c 91 0.42 (0.15 to 0.68)c 92
Urine RNA markers
No. of patient vs control group comparisons 14b NA 14b NA
Diagnostic group
DEM NA NA NA NA
SUB NA NA NA NA
PSY 0.52 (0.09 to 0.70)c NA 0.52 (0.09 to 0.70)c NA
BIP 0.73 (0.31 to 1.01)c NA 0.73 (0.31 to 1.01)c NA
MDD 0.21 (−0.33 to 0.38) NA 0.21 (−0.33 to 0.38) NA
ANX NA NA NA NA
Total 0.56 (0.21 to 0.90)c 87 0.56 (0.21 to 0.90)c 87

Abbreviations: ANX, anxiety disorders; BIP, bipolar disorders; DEM, dementia disorders; MDD, major depressive disorders; NA, not applicable; PSY, psychotic disorders; SUB, substance use disorders.

a

Data are standardized mean differences expressed as Hedges g (95% CIs), and heterogeneity is expressed by I2 values.

b

Tests of diagnostic group differences were significant (P < .05).

c

P < .05.